BRELGA

Glaxo Group Limited

Application Filed: 2014-07-28

Trademark Application Details

Status

602

Dead/Abandoned

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

Research	OneLook Acronym Finder
Serial Number	86349915
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Christopher M. Hanes
Attorney Docket Number	TMID/5100129
Law Office Assigned	L70
Employee Name	ALTREE, NICHOLAS

Timeline

2014-07-28	Application Filed
2015-11-13	Abandon
2015-11-27	Location: TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED
2015-11-27	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Glaxo Group Limited
Entity Statement	private company limited by shares (prc)
Address	980 Great West Road Brentford, Middles TW89GS GB2
Legal Entity Type
Legal Entity State	GB2

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

CHRISTOPHER M. HANES
GlaxoSmithKline
Legal Global Trademarks, Mailstop: 5.5A
Five Moore Drive
Research Triangle Park NC 27709-0183

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Type Code

Type

GS0051

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2014-07-31	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2014-08-05	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2014-11-10	3 DOCK D:Assigned to Examiner
SUSPENSION LETTER WRITTEN	2014-11-10	4 CNSL R:Renewal
LETTER OF SUSPENSION E-MAILED	2014-11-10	5 GNSL F:First Action
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED	2014-11-10	6 GNS3 O:Outgoing Correspondence
SUSPENSION INQUIRY WRITTEN	2015-05-11	7 CNSI R:Renewal
INQUIRY TO SUSPENSION E-MAILED	2015-05-11	8 GNSI S:
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED	2015-05-11	9 GNS2 O:Outgoing Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2015-06-22	10 TCCA I:Incoming Correspondence
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE	2015-11-27	11 ABN2 O:Outgoing Correspondence
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND	2015-11-30	12 MAB2 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.